Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trichuris suis ova (TSO) as an additional therapy for rheumatoid arthritis patients with insufficient response to methotrexate
DRKS00005323Phase 2Not yet recruiting
- Sponsor
- Immanuel Krankenhaus Berlin
- Start
- Oct 2013
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing TSO + methotrexate with Placebo + methotrexate (2 arms). Planned start Oct 2013; status: not yet recruiting.
02
Drugs
trichuris suis ova
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on DRKS00005323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005323.